Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Medeon Biodesign, Inc. (6499.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
27.86
P/B ratioShare price divided by book value per share.
6.48
P/S ratioMarket value divided by annual revenue.
18.62
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
13.10%
Operating marginRevenue left after operating costs.
-131.56%
Net marginRevenue left after every cost, including tax and interest.
-130.48%
Return on equityProfit as a percentage of shareholders’ equity.
-51.16%
Return on assetsProfit as a percentage of total assets.
-26.09%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
6.57
Quick ratioThe same, excluding inventory.
6.15
Debt to equityTotal borrowings against shareholders’ equity.
0.12
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-5.96
Book value per shareShareholders’ equity divided by shares outstanding.
$12.69
Shares outstandingShares currently issued.
96,944,893
Market capitalisationShare price times shares outstanding.
$7.97B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
1,496
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Medeon Biodesign, Inc. (6499.TWO) statistics — frequently asked questions
What is Medeon Biodesign, Inc.'s P/E ratio?
Medeon Biodesign, Inc. (6499.TWO) trades on a price-to-earnings ratio of 27.86.
What is Medeon Biodesign, Inc.'s return on equity?
Medeon Biodesign, Inc. (6499.TWO) reports a return on equity of -51.16%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Medeon Biodesign, Inc. carry?
Medeon Biodesign, Inc. (6499.TWO) has a debt-to-equity ratio of 0.12, which compares total borrowings with shareholders' equity.
What is Medeon Biodesign, Inc.'s profit margin?
Medeon Biodesign, Inc. (6499.TWO) keeps -130.48% of revenue as net profit after every cost, including tax and interest.